Similar articles

• Screening for Down's syndrome--too many choices?

  Mennuti MT, Driscoll DA. Mennuti MT, et al. N Engl J Med. 2003 Oct 9;349(15):1471-3. doi: 10.1056/NEJMe038135. N Engl J Med. 2003. PMID: 14534341 No abstract available.
• First-trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?

  Thilaganathan B. Thilaganathan B. Ultrasound Obstet Gynecol. 1999 Apr;13(4):229-30. doi: 10.1046/j.1469-0705.1999.13040229.x. Ultrasound Obstet Gynecol. 1999. PMID: 10341398 Review. No abstract available.
• First-trimester or second-trimester screening, or both, for Down's syndrome.

  Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. Malone FD, et al. N Engl J Med. 2005 Nov 10;353(19):2001-11. doi: 10.1056/NEJMoa043693. N Engl J Med. 2005. PMID: 16282175 Clinical Trial.
• First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.

  Orlandi F, Damiani G, Hallahan TW, Krantz DA, Macri JN. Orlandi F, et al. Ultrasound Obstet Gynecol. 1997 Dec;10(6):381-6. doi: 10.1046/j.1469-0705.1997.10060381.x. Ultrasound Obstet Gynecol. 1997. PMID: 9476320
• First trimester screening for Down syndrome in multiple pregnancy.

  Cleary-Goldman J, Berkowitz RL. Cleary-Goldman J, et al. Semin Perinatol. 2005 Dec;29(6):395-400. doi: 10.1053/j.semperi.2006.01.002. Semin Perinatol. 2005. PMID: 16533653 Review.